BAILEE HAMILTON: Open Payments
NPI 1598450470 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 31 payments from 11 companies in 2025. Trend: 2023 $178 · 2024 $530 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $135 |
| PFIZER INC. | 2 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $83 |
| Indivior Inc. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Inspire Medical Systems, Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, SPRAVATO, ZAVZPRET, SUBLOCADE, XIFAXAN, NURTEC ODT, TZIELD.
Industry payments across UT — which companies pay providers there.
